Education
About Us
Working with TipRanks
Follow Us
Labcorp Holdings (LH)
NYSE:LH
LH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$191.97 - $258.59
Previous CloseN/A
Volume103.18K
Average Volume (3M)885.42K
Market Cap
$20.17B
Enterprise Value$25.08B
Total Cash (Recent Filing)$99.30M
Total Debt (Recent Filing)$5.97B
Price to Earnings (P/E)27.8
Beta0.39
Next Earnings
Jul 31, 2025EPS Estimate
4.19Next Dividend Ex-Date
May 29, 2025Dividend Yield1.2%
Share Statistics
EPS (TTM)8.67
Shares Outstanding83,700,000
10 Day Avg. Volume932,232
30 Day Avg. Volume885,421
Financial Highlights & Ratios
PEG Ratio0.37
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.24
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.16
Enterprise Value/Ebitda15.39
Forecast
1Y Price Target
$271.09Price Target Upside12.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
---
Bulls Say, Bears Say
Bulls Say
Company StrategyHospital outreach M&A and collaboration activity are being used by LH to bolster volume growth and improve overall margins.
Financial PerformanceLabcorp's first-quarter results were 3% ahead of consensus earnings per share.
Guidance And OutlookManagement reiterated its full-year revenue guidance and raised its adjusted EPS outlook by $0.05 to $16.05.
Bears Say
Industry RisksThe FDA's plan to phase out animal testing could be a potential overhang for Labcorp Holdings' Early Development unit.
Revenue ExpectationsLabcorp fell short of consensus revenue expectations by 2% due to weather-related headwinds impacting diagnostics and lower COVID-19 vaccine revenue.
Segment PerformanceBoth the Lab segment and Biopharma Laboratory Services came in below expectations, indicating challenges in meeting revenue targets.
---
Ownership Overview
0.34% Insiders
27.90% Mutual Funds
0.54% Other Institutional Investors
46.93% Public Companies and
Individual Investors
LH FAQ
What was Labcorp Holdings’s price range in the past 12 months?
Labcorp Holdings lowest stock price was $191.97 and its highest was $258.59 in the past 12 months.
What is Labcorp Holdings’s market cap?
Labcorp Holdings’s market cap is $20.17B.
When is Labcorp Holdings’s upcoming earnings report date?
Labcorp Holdings’s upcoming earnings report date is Jul 31, 2025 which is in 90 days.
How were Labcorp Holdings’s earnings last quarter?
Labcorp Holdings released its earnings results on Apr 29, 2025. The company reported $3.84 earnings per share for the quarter, beating the consensus estimate of $3.742 by $0.098.
Is Labcorp Holdings overvalued?
According to Wall Street analysts Labcorp Holdings’s price is currently Undervalued.
Does Labcorp Holdings pay dividends?
Labcorp Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 1.2%. See more information on Labcorp Holdings dividends here
What is Labcorp Holdings’s EPS estimate?
Labcorp Holdings’s EPS estimate is 4.19.
How many shares outstanding does Labcorp Holdings have?
Labcorp Holdings has 83,700,000 shares outstanding.
What happened to Labcorp Holdings’s price movement after its last earnings report?
Labcorp Holdings reported an EPS of $3.84 in its last earnings report, beating expectations of $3.742. Following the earnings report the stock price went up 4.713%.
Which hedge fund is a major shareholder of Labcorp Holdings?
Currently, no hedge funds are holding shares in LH
---
Labcorp Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$271.09 (12.35% Upside)
$271.09 (12.35% Upside)
Blogger Sentiment
Neutral
LH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 19.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $805.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 2.9%
Last 30 Days ▲ 2.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
21.20%
12-Months-Change
Fundamentals
Return on Equity
8.98%
Trailing 12-Months
Asset Growth
6.49%
Trailing 12-Months
Company Description
Labcorp Holdings
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
---
LH Company Deck
---
LH Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with strong revenue growth, strategic acquisitions, and innovative test launches. However, there were concerns regarding tariff impacts, regulatory changes, and weather-related disruptions affecting margins.Read More>---
LH Revenue Breakdown
77.98% Dx
22.47% BLS
---
LH Stock 12 Month Forecast
Average Price Target
$271.09
▲(12.35% Upside)
Technical Analysis
---